Search results
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing -...
Benzinga via Yahoo Finance· 10 hours agoPharmaceutical companies have been at the forefront of artificial intelligence for quite some time....
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoTeva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript May 8, 2024 Teva...
Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 2 days agoEarnings per share (EPS) missed analyst estimates by 149%. Looking ahead, revenue is forecast to...
Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo Finance· 3 days agoAlthough the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its...
The impact of smart packaging in pharmaceutical logistics
Packaging Gateway via Yahoo Finance· 3 days agoIn the pharmaceutical industry, logistics is not just about transportation but ensuring that...
Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)
Simply Wall St. via Yahoo Finance· 20 hours agoThe company's share price is broadly unchanged from a week ago. Balance Sheet Analysis Just as...
Teva Pharmaceutical Industries (NYSE:TEVA) shareholders have earned a 54% return over the last year
Simply Wall St. via Yahoo Finance· 5 days agoThese days it's easy to simply buy an index fund, and your returns should (roughly) match the...
Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 20 hours agoEarnings per share (EPS) also surpassed analyst estimates by 15%. Looking ahead, revenue is forecast...
Teva Pharmaceutical Industries Posts Narrower Loss In Q1 - Update
RTT News· 3 days agoTeva Pharmaceutical Industries Ltd. (TEVA) posted a first quarter net loss attributable to Teva of $139 million or $0.12 per share, compared to a net loss of $220 million and $0.20, per share ...
Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise
Market Watch· 3 days agoTeva Pharmaceutical Industries stock jumped more than 6% early Wednesday after the company reported...